| |
| |
|
| Insider
Information: |
Oneil Patrick R. |
| Relationship: |
EVP CLO & General Coun... |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
48,661 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,991,695 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
48,661 |
|
|
| Total
Value |
$1,991,695 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -29.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
EVP CLO & General Coun... |
2024-02-02 |
48,661 |
2013-01-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2024-02-02 |
4 |
S |
$49.67 |
$97,410 |
D/D |
(1,961) |
48,661 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,820 |
50,622 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2024-01-25 |
4 |
S |
$51.75 |
$333,788 |
D/D |
(6,450) |
46,802 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2024-01-17 |
4 |
S |
$50.42 |
$390,429 |
D/D |
(7,744) |
53,252 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2024-01-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,641 |
60,996 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2023-12-26 |
4 |
OE |
$47.34 |
$985,856 |
D/D |
20,825 |
61,180 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2023-12-26 |
4 |
S |
$51.46 |
$1,071,717 |
D/D |
(20,825) |
40,355 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2023-05-24 |
4 |
AS |
$41.70 |
$63,676 |
D/D |
(1,527) |
40,355 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2023-02-28 |
4 |
A |
$30.52 |
$9,185 |
D/D |
301 |
41,882 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2023-02-06 |
4 |
S |
$40.86 |
$78,460 |
D/D |
(1,920) |
41,581 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2023-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,822 |
43,501 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2023-01-31 |
4 |
AS |
$39.71 |
$178,700 |
D/D |
(4,500) |
39,679 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2023-01-30 |
4 |
AS |
$39.42 |
$177,372 |
D/D |
(4,500) |
44,179 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2023-01-18 |
4 |
S |
$39.49 |
$309,480 |
D/D |
(7,836) |
48,679 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2023-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,871 |
56,515 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2022-08-31 |
4 |
A |
$28.97 |
$3,129 |
D/D |
108 |
34,644 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2022-04-12 |
4 |
AS |
$40.06 |
$272,057 |
D/D |
(6,792) |
34,536 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2022-02-28 |
4 |
A |
$28.37 |
$20,854 |
D/D |
735 |
41,328 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2022-01-18 |
4 |
D |
$30.12 |
$225,930 |
D/D |
(7,501) |
40,593 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP CLO & General Counsel |
• – – |
2022-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,086 |
48,094 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP Legal & General Counsel |
• – – |
2021-08-31 |
4 |
A |
$33.80 |
$10,443 |
D/D |
309 |
27,008 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2021-02-26 |
4 |
A |
$44.54 |
$8,774 |
D/D |
197 |
26,699 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2021-01-25 |
4 |
AS |
$63.50 |
$338,074 |
D/D |
(5,324) |
26,502 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2021-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,504 |
37,682 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP & General Counsel |
• – – |
2021-01-15 |
4 |
D |
$61.28 |
$358,856 |
D/D |
(5,856) |
31,826 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
